Cargando…

Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis

AIM: To confirm previous conclusions on Saccharomyces cerevisiae (S. cerevisiae) CNCM I-3856 for irritable bowel syndrome (IBS) management. METHODS: An individual patient data meta-analysis was performed on two randomized clinical trials studying the effect of S. cerevisiae CNCM I-3856 supplementati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cayzeele-Decherf, Amélie, Pélerin, Fanny, Leuillet, Sébastien, Douillard, Benoit, Housez, Béatrice, Cazaubiel, Murielle, Jacobson, Gunnard K, Jüsten, Peter, Desreumaux, Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Meta-Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5236513/ https://www.ncbi.nlm.nih.gov/pubmed/28127207 http://dx.doi.org/10.3748/wjg.v23.i2.336

Ejemplares similares

Randomized double blind placebo-controlled trial of Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: improvement in abdominal pain and bloating in those with predominant constipation
por: Spiller, Robin, et al.
Publicado: (2015)

Saccharomyces cerevisiae CNCM I-3856 as a New Therapeutic Agent Against Oropharyngeal Candidiasis
por: Roselletti, Elena, et al.
Publicado: (2019)

Saccharomyces cerevisiae I-3856 in irritable bowel syndrome with predominant constipation
por: Mourey, Florian, et al.
Publicado: (2022)

Anti-Biofilm Properties of Saccharomyces cerevisiae CNCM I-3856 and Lacticaseibacillus rhamnosus ATCC 53103 Probiotics against G. vaginalis
por: Sabbatini, Samuele, et al.
Publicado: (2020)

Recovery of Saccharomyces cerevisiae CNCM I-3856 in Vaginal Samples of Healthy Women after Oral Administration
por: Decherf, Amelie, et al.
Publicado: (2020)

Therapeutic activity of a Saccharomyces cerevisiae-based probiotic and inactivated whole yeast on vaginal candidiasis
por: Pericolini, Eva, et al.
Publicado: (2016)

Saccharomyces cerevisiae–based probiotic as novel anti-microbial agent for therapy of bacterial vaginosis
por: Sabbatini, Samuele, et al.
Publicado: (2018)

Probiotic Yeast Therapy for Irritable Bowel Syndrome
por: Pélerin, Fanny, et al.
Publicado: (2016)

Multi-targeted properties of the probiotic saccharomyces cerevisiae CNCM I-3856 against enterotoxigenic escherichia coli (ETEC) H10407 pathogenesis across human gut models
por: Roussel, Charlène, et al.
Publicado: (2021)

Glycemic Index and Insulinemic Index of Foods: An Interlaboratory Study Using the ISO 2010 Method
por: Wolever, Thomas M.S., et al.
Publicado: (2019)

Probiotic strain Bacillus subtilis CU1 stimulates immune system of elderly during common infectious disease period: a randomized, double-blind placebo-controlled study
por: Lefevre, Marie, et al.
Publicado: (2015)

Safety and efficacy of selenium‐enriched yeast (Saccharomyces cerevisiae CNCM I‐3399) for all animal species
por: Rychen, Guido, et al.
Publicado: (2017)

Efficacy of Levucell(®) SB (Saccharomyces cerevisiae CNCM I‐1079) as a feed additive for weaned piglets
por: Rychen, Guido, et al.
Publicado: (2017)

Safety and efficacy of Levucell(®) SB (Saccharomyces cerevisiae CNCM I‐1079) as a feed additive for all pigs
por: Bampidis, Vasileios, et al.
Publicado: (2019)

Safety and efficacy of Levucell(®) SB (Saccharomyces cerevisiae CNCM I‐1079) as a feed additive for turkeys for fattening
por: Bampidis, Vasileios, et al.
Publicado: (2019)

Assessment of the application for renewal of authorisation of Levucell SC (Saccharomyces cerevisiae CNCM I‐1077) as a feed additive for lambs and horses
por: Bampidis, Vasileios, et al.
Publicado: (2019)

Assessment of the application for renewal of authorisation of selenium‐enriched yeast produced by Saccharomyces cerevisiae CNCM I‐3399 for all animal species
por: Bampidis, Vasileios, et al.
Publicado: (2020)

Effect of a high bicarbonate mineral water on fasting and postprandial lipemia in moderately hypercholesterolemic subjects: a pilot study
por: Zair, Yassine, et al.
Publicado: (2013)

Assessment of the application for renewal of the authorisation of Actisaf(®) Sc 47 (Saccharomyces cerevisiae CNCM I‐4407) as a feed additive for calves for rearing
por: Bampidis, Vasileios, et al.
Publicado: (2020)

Assessment of the application for renewal of authorisation of selenomethionine produced by Saccharomyces cerevisiae CNCM I‐3060 (selenised yeast inactivated) for all animal species
por: Bampidis, Vasileios, et al.
Publicado: (2018)

Safety and efficacy of Levucell(®) SB (Saccharomyces cerevisiae CNCM I‐1079) as a feed additive for chickens for fattening and minor poultry species
por: Rychen, Guido, et al.
Publicado: (2017)

Assessment of the application for renewal of authorisation of Levucell(®) SC (Saccharomyces cerevisiae CNCM I‐1077) as a feed additive for dairy ewes and dairy goats
por: Bampidis, Vasileios, et al.
Publicado: (2018)

Dietary Saccharomyces cerevisiae boulardii CNCM I-1079 Positively Affects Performance and Intestinal Ecosystem in Broilers during a Campylobacter jejuni Infection
por: Massacci, Francesca Romana, et al.
Publicado: (2019)

Safety and efficacy of the feed additive consisting of selenium‐enriched yeast (Saccharomyces cerevisiae CNCM I‐3060) for all animal species (Alltech Ireland)
por: Bampidis, Vasileios, et al.
Publicado: (2021)

Effect of Feeding Saccharomyces cerevisiae boulardii CNCM I-1079 to Sows and Piglets on Piglets’ Immune Response after Vaccination against Actinobacillus pleuropneumoniae
por: Bravo de Laguna, Fernando, et al.
Publicado: (2022)

Influence of Saccharomyces boulardii CNCM I-745on the gut-associated immune system
por: Stier, Heike, et al.
Publicado: (2016)

Diversity of Saccharomyces boulardii CNCM I-745 mechanisms of action against intestinal infections
por: Czerucka, Dorota, et al.
Publicado: (2019)

Safety and efficacy of Levucell(®) SC (Saccharomyces cerevisiae CNCM I‐1077) as a feed additive for dairy cows, cattle for fattening, minor ruminant species and camelids
por: Rychen, Guido, et al.
Publicado: (2017)

Assessment of the application for renewal of authorisation of Actisaf(®) Sc47 (Saccharomyces cerevisiae CNCM I‐4407) for lambs for fattening, minor dairy ruminants, horses and pigs for fattening
por: Rychen, Guido, et al.
Publicado: (2018)

Safety and efficacy of Actisaf(®) Sc47 (Saccharomyces cerevisiae CNCM I‐4407) as a feed additive for cattle for fattening, dairy cows, weaned piglets and sows
por: Bampidis, Vasileios, et al.
Publicado: (2019)

Safety and efficacy of Levucell SC (®) (Saccharomyces cerevisiae CNCM I‐1077) as a feed additive for calves and minor ruminant species and camelids at the same developmental stage
por: Bampidis, Vasileios, et al.
Publicado: (2019)

Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS
por: Brun, Paola, et al.
Publicado: (2017)

Unique Properties of Yeast Probiotic Saccharomyces boulardii CNCM I-745: A Narrative Review
por: Gopalan, Sarath, et al.
Publicado: (2023)

Safety and efficacy of a feed additive consisting of Saccharomyces cerevisiae CNCM I‐1079 for calves, all other ruminant species and camelids for rearing and for fattening (Danstart Ferment AG)
por: Bampidis, Vasileios, et al.
Publicado: (2022)

The Efficacy of Saccharomyces boulardii CNCM I-745 in Addition to Standard Helicobacter pylori Eradication Treatment in Children
por: Bin, Zhang, et al.
Publicado: (2015)

Correction: Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS
por: Brun, Paola, et al.
Publicado: (2017)

Saccharomyces boulardii CNCM I-745 Improves Intestinal Enzyme Function: A Trophic Effects Review
por: Moré, Margret I, et al.
Publicado: (2018)

Beneficial effects of Saccharomyces boulardii CNCM I-745 on clinical disorders associated with intestinal barrier disruption
por: Terciolo, Chloe, et al.
Publicado: (2019)

Efficacy and safety of non-pharmacological interventions for irritable bowel syndrome in adults
por: Dai, Yun-Kai, et al.
Publicado: (2020)

Safety and efficacy of a feed additive consisting of Bacillus subtilis strains CNCM I‐4606, CNCM I‐5043 and CNCM I‐4607 and Lactococcus lactis CNCM I‐4609 for all animal species (Nolivade)
por: Bampidis, Vasileios, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mi1a3qkt587hhptkk57rvnjb4g